Boule Diagnostics updates India licensing pact with Q-Line Biotech

Boule Diagnostics revised its licensing agreement with Q-Line Biotech to simplify its commercial structure in India, aiming to accelerate growth and expand its installed base of hematology systems. The new framework is designed to align incentives for scaling sales of analyzers, reagents, and consumables, with expectations of benefiting from upcoming public healthcare tenders and wider adoption of RFID-enabled laboratory workflows.